Skip to main content

Oculis Holding AG

OCSAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001953530

No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.

Other share classesOCS

Q3 2023 vs. Q2 2023

How the institutions holding Oculis Holding AG changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of OCSAW: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders2524−1
Shares976.3K821.2K−155.1K (−15.9%)
Value$1.07M$1.35M+$278.1K (+25.9%)

New holders (0)

Institutions that held Oculis Holding AG at the end of Q3 2023 but not at the end of Q2 2023.

None.

Sold out (1)

Institutions that held Oculis Holding AG at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of OCSAW in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Meteora Capital, LLC18,000$19.8K